Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Aleksandra Galetin, PhD (she/her/hers)

Professor of Translational Pharmacokinetics
University of Manchester
Manchester, England, United Kingdom

Aleksandra Galetin, PhD
Centre for Applied Pharmacokinetic Research, University of Manchester, UK

Dr Galetin is a Professor of Translational Pharmacokinetics in the School of Health Sciences, University of Manchester, UK and Deputy Director of the Centre for Applied Pharmacokinetic Research. She is currently President of International Society for the Study of Xenobiotics (ISSX), in addition to her service on the ISSX Council. Dr Galetin holds long-standing leadership position in the International Transporter Consortium (ITC) where she led multiple white papers defining best practices for the application of endogenous biomarkers and PBPK modelling of transporter-mediated drug-drug interactions among others topics. Dr Galetin had her sabbatical in the US FDA Office of Clinical Pharmacology where she provided expert advice on the PBPK modelling of drug-drug interactions and prediction of PK in specific patient populations in new drug applications. She has published extensively and supervised/mentored over 40 graduate students and postdoctoral research associates.

Disclosure(s): Abbvie: Grant/Research Support (Ongoing); Bristol Myers Squibb: Grant/Research Support (Ongoing); Eli Lilly and Company: Grant/Research Support (Ongoing); EMD Serono, Merck kGa: Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); GSK: Grant/Research Support (Ongoing); Janssen Research & Development: Grant/Research Support (Ongoing); Roche: Employment (Ongoing), Grant/Research Support (Ongoing); Servier: Grant/Research Support (Ongoing); Takeda: Grant/Research Support (Ongoing)

Presentation(s):